Northern Trust’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.1M Sell
828,508
-25,041
-3% -$426K ﹤0.01% 1867
2025
Q1
$16.7M Buy
853,549
+113,043
+15% +$2.21M ﹤0.01% 1738
2024
Q4
$18.4M Buy
740,506
+49,415
+7% +$1.23M ﹤0.01% 1746
2024
Q3
$16.9M Buy
691,091
+33,709
+5% +$826K ﹤0.01% 1728
2024
Q2
$15.4M Sell
657,382
-1,798
-0.3% -$42.1K ﹤0.01% 1721
2024
Q1
$21.8M Sell
659,180
-9,362
-1% -$309K ﹤0.01% 1535
2023
Q4
$18.2M Buy
668,542
+13,934
+2% +$379K ﹤0.01% 1678
2023
Q3
$15.7M Buy
654,608
+29,646
+5% +$713K ﹤0.01% 1710
2023
Q2
$20M Buy
624,962
+16,998
+3% +$543K ﹤0.01% 1585
2023
Q1
$18.6M Sell
607,964
-4,886
-0.8% -$150K ﹤0.01% 1604
2022
Q4
$24M Buy
612,850
+8,410
+1% +$329K 0.01% 1414
2022
Q3
$28.8M Buy
604,440
+42,337
+8% +$2.02M 0.01% 1218
2022
Q2
$21.8M Buy
562,103
+101,060
+22% +$3.91M ﹤0.01% 1466
2022
Q1
$26.4M Sell
461,043
-18,915
-4% -$1.08M ﹤0.01% 1477
2021
Q4
$38.2M Buy
479,958
+1,061
+0.2% +$84.5K 0.01% 1299
2021
Q3
$41.7M Buy
478,897
+25,323
+6% +$2.2M 0.01% 1230
2021
Q2
$58.4M Buy
453,574
+50,817
+13% +$6.54M 0.01% 1008
2021
Q1
$32.2M Sell
402,757
-24,400
-6% -$1.95M 0.01% 1483
2020
Q4
$34.9M Buy
427,157
+45,101
+12% +$3.68M 0.01% 1375
2020
Q3
$9.41M Buy
382,056
+214,813
+128% +$5.29M ﹤0.01% 2145
2020
Q2
$4.68M Buy
167,243
+36,217
+28% +$1.01M ﹤0.01% 2568
2020
Q1
$2.36M Buy
+131,026
New +$2.36M ﹤0.01% 2763